- Home
- CERS vs HFRO Comparison
CERS vs HFRO Comparison
Compare CERS & HFRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERS
- HFRO
- Stock Information
- Founded
- CERS 1991
- HFRO 2000
- Country
- CERS United States
- HFRO United States
- Employees
- CERS N/A
- HFRO N/A
- Industry
- CERS EDP Services
- HFRO Finance/Investors Services
- Sector
- CERS Technology
- HFRO Finance
- Exchange
- CERS Nasdaq
- HFRO Nasdaq
- Market Cap
- CERS 324.3M
- HFRO 402.7M
- IPO Year
- CERS 1997
- HFRO N/A
- Fundamental
- Price
- CERS $1.63
- HFRO $5.87
- Analyst Decision
- CERS Buy
- HFRO
- Analyst Count
- CERS 3
- HFRO 0
- Target Price
- CERS $3.17
- HFRO N/A
- AVG Volume (30 Days)
- CERS 1.6M
- HFRO 421.7K
- Earning Date
- CERS 10-31-2024
- HFRO 01-01-0001
- Dividend Yield
- CERS N/A
- HFRO 12.00%
- EPS Growth
- CERS N/A
- HFRO N/A
- EPS
- CERS N/A
- HFRO 1.23
- Revenue
- CERS $169,984,000.00
- HFRO $44,535,929.00
- Revenue This Year
- CERS $15.25
- HFRO N/A
- Revenue Next Year
- CERS $10.89
- HFRO N/A
- P/E Ratio
- CERS N/A
- HFRO $5.50
- Revenue Growth
- CERS 10.79
- HFRO N/A
- 52 Week Low
- CERS $1.21
- HFRO $5.92
- 52 Week High
- CERS $2.59
- HFRO $9.38
- Technical
- Relative Strength Index (RSI)
- CERS 37.45
- HFRO 35.00
- Support Level
- CERS $1.71
- HFRO $5.82
- Resistance Level
- CERS $1.94
- HFRO $6.24
- Average True Range (ATR)
- CERS 0.11
- HFRO 0.13
- MACD
- CERS 0.01
- HFRO -0.04
- Stochastic Oscillator
- CERS 43.59
- HFRO 10.42
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
About HFRO Highland Opportunities and Income Fund of Beneficial Interest
Highland Opportunities and Income Fund is a non-diversified, closed-end management investment company. Its investment objective is to Income Fund seeks growth of capital along with income. The company's portfolio of investments includes different industry investments such as Financial, Communication Services, Energy, Healthcare, Materials, and others.